The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
Lei Zhang,Huan-Huan Liu,Feng Li,Fan Yang,Ling-Ling Qian,Ru-Xing Wang
DOI: https://doi.org/10.2147/jir.s390310
IF: 4.5
2022-12-29
Journal of Inflammation Research
Abstract:Lei Zhang, 1, &ast Huan-Huan Liu, 2, &ast Feng Li, 1 Fan Yang, 1 Ling-Ling Qian, 1 Ru-Xing Wang 1 1 Department of Cardiology, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi, People's Republic of China; 2 Wuxi School of Medicine, Jiangnan University, Wuxi, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ru-Xing Wang, Tel +86-510-85351593, Fax +86-510-85350555, Email Diabetes is a significant risk factor for arrhythmias. However, the pathophysiology of diabetes-related arrhythmias still needs to be elucidated, presumably associated with structural and electrical remodeling. There is growing evidence that inflammation and arrhythmias are intimately associated, which has spurred significant interest in exploring the regulatory links in diabetes. Recent research findings have revealed a vital role for the NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome signaling, and facilitated the occurrence of arrhythmias in diabetes, including NLRP3 inflammasome activation by multiple stressors and its downstream cytokines, interleukin-1β (IL-1β) and interleukin-18 (IL-18). This narrative review aims to summarize the complex interaction between NLRP3 inflammasomes signaling and diabetes-related arrhythmias. Articles regarding the role of NLRP3 inflammasome in diabetes-related arrhythmias and relevant mechanisms were selected. Relevant articles were selected from PubMed. The search terms were "NLRP3 inflammasome" and "diabetes" and "arrhythmia". Important references from selected articles were also retrieved. The role of NLRP3 inflammasome signaling in diabetes-induced arrhythmias may provide a new option for the prevention and treatment diabetes-related arrhythmias. Keywords: NLRP3, inflammasome, diabetes, arrhythmia Diabetes is a chronic metabolic disease characterized by hyperglycemia because of insulin resistance, insulin resistance, or both. 1 Data from the International Diabetes Federation showed that 10.5% (536.6 million) of people worldwide suffered from diabetes in 2021, and the incidence is still rising. 2 As a definite risk factor for cardiovascular disease, diabetes is significantly involved in the development of arrhythmias, including atrial arrhythmias, 3 ventricular arrhythmias, 4 and sudden death, 5 accompanied by a significant global disease burden and increased mortality. 6 Diabetes is associated with a chronic low-grade inflammatory state and can lead to negative remodeling of myocardial tissue. Advancing inflammatory response has been proven related to the development of arrhythmias. 7,8 The NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome is a crucial mediator of the innate immune system and can promote the activation of caspase-1, which in turn leads to the maturation and secretion of the pro-inflammatory cytokines, interleukin-1β (IL-1β) and interleukin-18 (IL-18), triggering an inflammatory cascade and causing irreparable damage of target organs. 9,10 In recent years, few reviews have summarized the role of NLRP3 inflammasome in diabetes and its complications. 11,12 However, those reviews are limited to focusing on the association between NLRP3 inflammasome activation and arrhythmias. A growing number of recent studies have suggested that the increased expression of NLRP3, caspase-1, IL-1β, and IL-18 in the cardiac tissue drives electrical and structural remodeling and progresses the arrhythmogenic substrate to further enhance the development of arrhythmias in diabetes. 7,13,14 This review aimed to summarize the contributing role of the NLRP3 inflammasome signaling, including NLRP3 inflammasome, caspase-1, IL-1β and IL-18, in arrhythmogenesis of diabetes. The underlying mechanisms might provide insight into the prevention and treatment of diabetes-related arrhythmias. Inflammasomes, a key actor of innate inflammatory signaling, serve as the first defense response to danger signals such as pathogens (viruses, bacteria) or molecules. Inflammasomes are classified into the canonical inflammasomes that activate caspase-1 and the noncanonical inflammasomes that activate caspase-4/5/11. 15 NLRP3 inflammasome is a canonical inflammasome typically composed of NLRP3, apoptosis-associated speck-like protein containing a CARD (ASC) and pro-caspase-1. 16 Typically, a two-step process is required for the activation of NLRP3 inflammasome that involves priming and activation (Figure 1). External stimuli are sensed by cells, such as exogenous pathogen-associated molecular patterns (PAMPs) or endogenous damage-associated molecular patterns (DAMPs), and then the -Abstract Truncated-
immunology